Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.
作者信息
Dumortier Jérôme
机构信息
Hospices civils de Lyon, Edouard Herriot hospital, Department of Digestive Diseases, France; Claude Bernard Lyon 1 University, Lyon, France.
出版信息
Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101743. doi: 10.1016/j.clinre.2021.101743. Epub 2021 Jun 16.
Abstract
摘要
相似文献
1
Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.
Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101743. doi: 10.1016/j.clinre.2021.101743. Epub 2021 Jun 16.
2
Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant Recipients.
Transplantation. 2022 Jul 1;106(7):e341-e342. doi: 10.1097/TP.0000000000004147. Epub 2022 Mar 23.
3
Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.
4
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma.
BMC Cancer. 2021 Dec 27;21(1):1354. doi: 10.1186/s12885-021-09097-5.
5
New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant?
J Hepatol. 2022 Jan;76(1):218-220. doi: 10.1016/j.jhep.2021.08.006. Epub 2021 Aug 25.
6
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients.
Kidney Int. 2022 May;101(5):1073-1076. doi: 10.1016/j.kint.2022.02.011. Epub 2022 Feb 26.
7
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
8
Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort.
Front Immunol. 2021 Dec 2;12:780594. doi: 10.3389/fimmu.2021.780594. eCollection 2021.
9
Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients.
Liver Transpl. 2022 Jan;28(1):123-126. doi: 10.1002/lt.26351. Epub 2021 Dec 3.
10
Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
Am J Cardiol. 2022 Mar 15;167:155-157. doi: 10.1016/j.amjcard.2021.12.007. Epub 2022 Jan 19.
引用本文的文献
1
Elevated alanine transaminase in liver transplant recipients after BNT162b2 vaccination: a cohort study.
NPJ Vaccines. 2025 Aug 2;10(1):181. doi: 10.1038/s41541-025-01233-7.
2
Recent Patterns and Assessment of Long-term Complications followi ngSARS-CoV-2 Infection and Vaccination in the Context of Diabet esPrevalence among Blood Donors.
Curr Diabetes Rev. 2024;20(9):e110124225520. doi: 10.2174/0115733998274390231110050809.
3
The impact of COVID-19 on liver transplantation: challenges and perspectives.
Therap Adv Gastroenterol. 2023 May 10;16:17562848231171452. doi: 10.1177/17562848231171452. eCollection 2023.
4
Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review.
Clin J Gastroenterol. 2023 Aug;16(4):554-558. doi: 10.1007/s12328-023-01794-x. Epub 2023 Apr 7.
5
Efficacy of Vaccine Protection Against COVID-19 Virus Infection in Patients with Chronic Liver Diseases.
J Clin Transl Hepatol. 2023 Jun 28;11(3):718-735. doi: 10.14218/JCTH.2022.00339. Epub 2023 Jan 16.
6
Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohort.
Emerg Microbes Infect. 2022 Dec;11(1):2636-2644. doi: 10.1080/22221751.2022.2136535.
7
Safety and Humoral and Cellular Immunogenicity of the BNT162b2 SARS-CoV-2 Vaccine in Liver-Transplanted Adolescents Compared to Healthy Adolescents.
Vaccines (Basel). 2022 Aug 16;10(8):1324. doi: 10.3390/vaccines10081324.
8
Association of COVID-19 vaccination before conception with maternal liver function during early pregnancy: a cohort study of 7745 Chinese pregnant women.
Emerg Microbes Infect. 2022 Dec;11(1):2222-2228. doi: 10.1080/22221751.2022.2117100.
9
Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns.
Diagnostics (Basel). 2022 Jun 26;12(7):1555. doi: 10.3390/diagnostics12071555.
10
Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update.
Front Med (Lausanne). 2022 Jun 22;9:924454. doi: 10.3389/fmed.2022.924454. eCollection 2022.
Zotero 插件